4QBV
| |
4Q9P
| |
3Q7W
| |
3Q7Y
| |
3Q7X
| Crystal structure of Symfoil-4P/PV1: de novo designed beta-trefoil architecture with symmetric primary structure, primitive version 1 | Descriptor: | 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL, SULFATE ION, de novo designed beta-trefoil architecture with symmetric primary structure | Authors: | Blaber, M, Lee, J. | Deposit date: | 2011-01-05 | Release date: | 2012-01-11 | Last modified: | 2024-02-21 | Method: | X-RAY DIFFRACTION (1.4 Å) | Cite: | Simplified protein design biased for prebiotic amino acids yields a foldable, halophilic protein. Proc.Natl.Acad.Sci.USA, 110, 2013
|
|
3SNV
| |
3BA5
| |
3BAD
| |
3BA4
| |
3B9U
| |
3BA7
| |
3FJK
| |
3FJ9
| |
3FJB
| |
3FJI
| |
3FJ8
| |
3FJA
| |
3FJD
| |
3FJJ
| |
3FJC
| |
3FGM
| |
3FJF
| |
3FJE
| |
3FJH
| |
4YOL
| Human fibroblast growth factor-1 C16S/A66C/C117A/P134A | Descriptor: | CITRATE ANION, Fibroblast growth factor 1, IMIDAZOLE | Authors: | Xia, X, Blaber, M. | Deposit date: | 2015-03-11 | Release date: | 2016-03-16 | Last modified: | 2019-02-13 | Method: | X-RAY DIFFRACTION (1.97 Å) | Cite: | Engineering a Cysteine-Free Form of Human Fibroblast Growth Factor-1 for "Second Generation" Therapeutic Application. J.Pharm.Sci., 105, 2016
|
|